Stryker Corp. wants to be a leader in changing how acute stroke is treated in the US, moving it from a time-based approach to determine which patients can be treated with thrombectomy, to a physiology-based strategy that the company says will bring more effective therapy to more patients.
US FDA recently approved new labeling for Stryker’s Trevo Retriever thrombectomy device, indicating it as front-line treatment for acute ischemic...